Sigma-Aldrich Posts 7 Percent Q4 Revenue Growth | GenomeWeb

NEW YORK (GenomeWeb News) – Sigma-Aldrich today reported that its fourth-quarter 2012 revenues grew 7 percent, driven by strong sales for its SAFC business unit.

The St. Louis-based chemicals and research products firm reported total revenues of $655 million for the three months ended Dec. 31, compared to $610 million for the fourth quarter of 2011. It fell short of the consensus Wall Street estimate for revenues of $659.6 million. On an organic basis, the firm's revenues grew 3 percent.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Science this week: experts say race is not a sufficient proxy for studying human genetic diversity and more.

Technology Review writes that CRISPR/Cas9 gene editing firm Editas' success may hinge on a patent case.

Researchers unearthed a bioinformatics error in the Science paper reporting the first ancient African genome, and the authors are seeking an erratum.

A boy's cystic fibrosis carrier status was revealed by a teacher to the parents of children with CF who then sought the boy's transfer to another school, leading to a lawsuit.